Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 244 results found. Search for [ pharmaceutical manufacturers ]

Results 200 to 220 of 244
E. Kumar Sharma
February 11, 2014
In an exclusive interview with Business Today, Margaret Hamburg says companies must instill and maintain quality practices so they remain compliant with the FDA's requirements. This commitment to quality manufacturing must be accepted by everyone involved - from top CEOs to the foremen to line workers.

E. Kumar Sharma
February 11, 2014
The two countries agreed to cooperate on regulatory matters and establish better coordination between the inspectors of both the regulatory authorities.  

Bill Berkrot
February 8, 2014
The US Chamber of Commerce has requested that India be classified as a Priority Foreign Country, a tag given to the worst offenders when it comes to protecting intellectual property and one that could trigger trade sanctions.

Sumeet Chatterjee and Ben Hirschler
Mumbai/London, February 6, 2014
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent.

Suprotip Ghosh
December 23, 2013
Kamal K. Sharma came into Lupin after the company went through tough times. For one, the pharma firm was saddled with a massive Rs 500-crore debt. For another, it had missed the bus on global expansion while its peers such as Ranbaxy had started operations in the US.

New Delhi, November 27, 2013
The industry ministry and the health ministry have proposed that the government limit foreign ownership to 49 percent of domestic pharmaceutical firms that produce critical drugs such as vaccines and cancer treatment medicines.The finance ministry has opposed the  proposal.

New Delhi, September 24, 2013
The US health regulator's presence in India is being increased to 19 from 12 American staff based in-country, including 10 dedicated specifically to medical products.

New Delhi, August 5, 2013
Seven more pharmaceutical companies including Novartis India Limited on Monday moved the Delhi High Court to challenge the government's new drug pricing order that asked them to slash prices of 348 medicines.

New Delhi, July 27, 2013
The Delhi High Court asked the Centre not to take coercive steps against pharma major Cipla Ltd which has challenged a government order asking it to reduce prices of its 125 drugs within 45 days of issuance of the notification.

E. Kumar Sharma
July 3, 2013
In an emailed response to E. Kumar Sharma's questions, the USFDA informs that it is planning to expand its presence in India, including setting up another office in the country, in Hyderabad.

E. Kumar Sharma
June 15, 2013
A close look at the Indian pharmaceutical industry shows a complicated regulatory structure and a web of entities at the central and state levels tasked with monitoring the sector. The regulator is now getting a makeover but better enforcement and safer medicines are yet a chimera.

Kiran Mazumdar-Shaw
June 18, 2013
The issuing of manufacturing licences should be strictly regulated and the frequency of spot audits stepped up along with severe penalties for non-compliance, writes Biocon CMD Kiran Mazumdar-Shaw.

Associated Press
New Delhi, May 14, 2013
The Indian government announced on Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world.

E. Kumar Sharma
May 6, 2013
India is the world's third-largest pharmaceuticals market in terms of volumes, but competition is stiff to grab a slice of the rapidly growing business. Several small pharma companies are making a big difference in niche areas of health-care.

Washington, April 3, 2013
The US industry is reviewing the order of the Supreme Court that denied patent on Glivec, a cancer drug produced by Swiss drug maker Novartis, even as Corporate America expressed dismay at the court verdict.

Associated Press
New Delhi, March 5, 2013
The Intellectual Property Appellate Board has rejected Bayer AG's plea to stop Natco Pharma from producing a cheaper generic version of its patented cancer drug.

Sowmya Kamath
February 22, 2013
Stock exchanges release a list of illiquid stocks every quarter based on criteria decided by them and the market regulator. Mutual funds hold a few illiquid stocks. These stocks, most of which are not tracked by brokerage houses due to low public float, may turn out to be multi-baggers in the coming years.

Savita Verma
New Delhi, November 24, 2012
The National Pharmaceutical Pricing Policy approved by the Cabinet on Thursday could bring only little relief to patients in terms of price reduction because cheaper brands could turn costly. In addition, many drugs remain out of the price control mechanism.

Geetanjali Shukla
May 3, 2012
Dependence on China has generated enough concerns for the Indian Drug Manufacturers' Association to call for anti-dumping duties on some bulk drugs and intermediates from the country.

Pritam P Hans
Delhi, December 3, 2011
Investing is all about spotting the right opportunity. Places where big infrastructure and industrial projects come up see rapid growth, ensuring good returns on property investment. We explore some markets with huge growth potential.

PAGES 11 OF 13  111213